By
Martin Woods2020-09-16T17:52:00
In both the U.S. and U.K., millions (perhaps billions) of dollars of coronavirus relief loans intended for small businesses is believed to have been misused. Legitimate businesses have been hurt as a result, writes Martin Woods.
2020-05-08T19:34:00Z By Aaron Nicodemus
A House committee is demanding that large public companies that accepted Paycheck Protection Program loans meant for small businesses return them immediately.
2020-04-28T19:36:00Z By Aaron Nicodemus
Reacting to news the NBA’s Los Angeles Lakers received a coronavirus aid loan meant for small businesses, U.S. Treasury Sec. Steven Mnuchin said Tuesday all such loans over $2 million will be audited and some companies could face criminal liability.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
2025-12-01T16:04:00Z By Craig Conte, CW guest columnist
The only thing constant is change. Shouldn’t we be ready for that in our contracts?
2025-11-26T19:21:00Z By Tom Fox
AI decisions are only defensible when the reasoning behind them is visible, traceable, and auditable. Explainable AI delivers that visibility, turning black-box outputs into documented logic that compliance officers can stand behind when regulators, auditors, or stakeholders demand answers.
2025-11-19T16:06:00Z By Erik Swabb, Seth Locke and Barry Hurewitz, CW guest columnists
For emerging defense tech companies to take full advantage of acquisition reforms and increased funding, they will need to overcome a defining feature of the U.S. defense industry: It is highly regulated, and will likely remain so.
Site powered by Webvision Cloud